Lacosamide Solution
Product Images NDC 69315-318

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 69315-318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Containerlabel200ml (Containerlabel200ml)

FDA Label Image

Containerlabel465ml (Containerlabel465ml)

FDA Label Image

Lacosamide Fig 01 (Lacosamide Fig1)

FDA Label Image

Lacosamide Fig 02 (Lacosamide Fig2)

FDA Label Image

Lacosamide Fig 03 (Lacosamide Fig3)

This is a description of a figure showing the responder rate for different doses of Lacosamide compared to a placebo in three different studies. The figure shows the proportion of patients in each group who experienced improvement or worsening of their condition. The different doses of Lacosamide include 200mg/day, 400mg/day, and 600mg/day. The placebo group had a sample size of 359 patients, while the Lacosamide groups had sample sizes of 267, 466, and 202 respectively.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.